Mitochondrial oxidative stress is the achille's heel of melanoma cells resistant to Braf-mutant inhibitor

Vemurafenib/PLX4032, a selective inhibitor of mutant BRAFV600E, constitutes a paradigm shift in melanoma therapy. Unfortunately, acquired resistance, which unavoidably occurs, represents one major limitation to clinical responses. Recent studies have highlighted that vemurafenib activated oxidative...

Descripción completa

Detalles Bibliográficos
Autores principales: Corazao-Rozas, Paola, Guerreschi, Pierre, Jendoubi, Manel, André, Fanny, Jonneaux, Aurélie, Scalbert, Camille, Garçon, Guillaume, Malet-Martino, Myriam, Balayssac, Stéphane, Rocchi, Stephane, Savina, Ariel, Formstecher, Pierre, Mortier, Laurent, Kluza, Jérome, Marchetti, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2013
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875764/
https://www.ncbi.nlm.nih.gov/pubmed/24161908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875764/
https://www.ncbi.nlm.nih.gov/pubmed/24161908

Ejemplares similares